When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Essure - Wikipedia

   en.wikipedia.org/wiki/Essure

   Of the 745 women with implants in the original premarket studies, 92% were followed up at one year, and 25% for two years, for safety outcomes. A 2009 review concluded that Essure appeared safe and effective based on short-term studies, that it was less invasive and could be cheaper than laparoscopic bilateral tubal ligation. [ 2 ]

3. Transvaginal mesh - Wikipedia

   en.wikipedia.org/wiki/Transvaginal_mesh

   Transvaginal mesh, also known as vaginal mesh implant, is a net-like surgical tool that is used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI) among female patients. The surgical mesh is placed transvaginally to reconstruct weakened pelvic muscle walls and to support the urethra or bladder. [1] [2]

4. FDA warning letter - Wikipedia

   en.wikipedia.org/wiki/FDA_Warning_Letter

   The FDA considers a warning letter informal and advisory. It communicates the agency's position on a matter, but does not commit the FDA to an enforcement action. For that reason, the FDA does not consider a warning letter a final action on which it can be sued. [3]

5. MiMedx reports US FDA warning letter for Axiofill, shares drop

   www.aol.com/news/mimedx-reports-us-fda-warning...

   Following a routine inspection this year, the FDA found Axiofill does not fall under Section 361 of the U.S. Public Health Service Act. MiMedx reports US FDA warning letter for Axiofill, shares ...

6. FDA Approves Abiomed's Impella Low Profile Sheath - AOL

   www.aol.com/news/fda-approves-abiomeds-impella...

   The FDA has granted 510(k) clearance to Abiomed Inc's (NASDAQ: ABMD) Impella Low Profile Sheath. Compared to the existing 14 French (Fr) sheath used for the placement of Impella CP, the new sheath ...

7. Quack Miranda warning - Wikipedia

   en.wikipedia.org/wiki/Quack_Miranda_warning

   The quack Miranda warning is a term used by skeptics to describe the text which the Dietary Supplement Health and Education Act of 1994 (DSHEA) requires that all labels and marketing materials for products sold as dietary supplements carry, in boldface type: [1] [2] These statements have not been evaluated by the Food and Drug Administration ...